ucb_logo

Family Planning and Pregnancy Initiative

New UCB initiative focused on Family Planning and Pregnancy in Immunological Diseases aims to bridge knowledge gaps

UCB is launching an innovative initiative to enhance awareness and improve understanding about family planning and pregnancy in immunological diseases such as rheumatoid arthritis, Crohn’s disease and lupus.

As a leading biopharmaceutical company UCB is committed to helping people with severe immunological diseases to lead active and fulfilling lives and we are proud to contribute to research, development and educational programs in this area aimed at advancing standards of care.
The UCB Family Planning & Pregnancy initiative in immunological diseases aims to:

  • Enhance awareness and improve understanding about family planning and pregnancy in immunological diseases
  • Stimulate research and scientific exchange to bridge gaps in knowledge in this area
  • Provide educational support so that people living with immunological diseases can have informed and meaningful discussions with their healthcare professional
  • Continue to address questions related to family planning and pregnancy in UCB’s  product portfolio for immunological diseases.

At UCB, everything we do starts with a simple question: “How will this make a difference to the lives of people with severe diseases?”.  We believe that this initiative has the potential to make a meaningful difference to the lives of many people living with immunological diseases today and in the future.

Find out more about UCB and the UCB initiative here: http://www.ucb.com/patients/conditions/family-planning-and-pregnancy-initiative